Clinical decision support tool predicts risk of infection in patients with inflammatory bowel disease treated with vedolizumab
Parambir Dulai 1
Ding Feng 2
Karen Lasch 2
1 University of California San Diego,La Jolla,United States
2 Takeda Pharmaceuticals USA Inc,Deerfield,United States
Session
IBD II (Posters)
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing